“We proactively pursued the amendment to our Supplier’s License to include copyright again in December 2022. We are going to evaluate how the commercialization of the substance suits in with our organization product at Adastra in an effort to situation ourselves to support the desire for a secure provide of copyright,” Adastra reported in an